Larvol Delta - Achilles-Therapeutics-to-Present-Early-Proof-of-Concept-of-Safety-and-Clinical-Activity-of-Clonal-Neoantigen-Reactive-T-Cells-at-the-ESMO-ImmunoOncology-Annual-Congress-2022

ATL 001 - Achilles Therap

https://www.globenewswire.com/news-release/2022/11/30/2565493/0/en/Achilles-Therapeutics-to-Present-Early-Proof-of-Concept-of-Safety-and-Clinical-Activity-of-Clonal-Neoantigen-Reactive-T-Cells-at-the-ESMO-Immuno-Oncology-Annual-Congress-2022.html

Nov 30, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next